Sign In
Buy ALPN
$64.97
+0 (+0%)
At Close: Aug 19, 2024
Alpine Immune Sciences: Q2 Earnings Insights
04:53pm, Tuesday, 10'th Aug 2021
Shares of Alpine Immune Sciences (NASDAQ:ALPN) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 13.21% year over year to ($0.46), w
Celldex: Powerful Medicines To Yield Further Upsides
03:15pm, Thursday, 08'th Jul 2021
Celldex: Powerful Medicines To Yield Further Upsides
Alpine Immune Sciences Initiates Trial Collaboration With Merck
11:17am, Wednesday, 30'th Jun 2021
Alpine Immune Sciences Inc (NASDAQ: ALPN) has entered into a clinical trial collaboration and supply agreement with Merck & Co Inc (NYSE: MRK). This collaboration will evaluate the safety and e
Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs
05:28am, Sunday, 13'th Jun 2021
Biogen isn't the only company whose shares should benefit from a breakthrough drug.
Alpine Immune Sciences Announces ALPN-202 Clinical Data Presented at the 2021 ASCO Virtual Annual Meeting
04:05pm, Friday, 04'th Jun 2021
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences Announces ALPN-202 Clinical Data Presented at the 2021 ASCO Virtual Annual Meeting
Alpine Immune Sciences' Autoimmune Disease Candidate ALPN-303 Shows Promise in Preclinical Studies
08:14am, Thursday, 03'rd Jun 2021
Alpine Immune Sciences Inc (NASDAQ: ALPN) has presented the preclinical data from its ALPN-303 program at the European Alliance of Associations for Rheumatology (EULAR) European Congress of Rheumat
Alpine Immune Sciences Presents ALPN-303 Data During the 2021 EULAR Virtual Meeting
04:05pm, Wednesday, 02'nd Jun 2021
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences Presents ALPN-303 Data During the 2021 EULAR Virtual Meeting
Alpine Immune Sciences: Better Days Ahead
03:50pm, Sunday, 30'th May 2021
Alpine Immune Sciences is a fundamental stock that is ideal for you to build a core long-term position. The company recently released preliminary NEON-1 data for the upcoming 2021 ASCO.
3 Biotech Stocks That Jumped Higher Last Week
06:43am, Sunday, 23'rd May 2021
Find out what pushed them up to see if the good times can keep rolling.
Alpine Immune Sciences, Inc. (ALPN) Moves 9.5% Higher: Will This Strength Last?
06:01am, Thursday, 20'th May 2021
Alpine Immune Sciences, Inc. (ALPN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there coul
Alpine Immune Sciences To Host Investor Event at 2021 ASCO Virtual Annual Meeting
05:10pm, Wednesday, 19'th May 2021
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences To Host Investor Event at 2021 ASCO Virtual Annual Meeting
Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Lags Revenue Estimates
07:41pm, Thursday, 13'th May 2021
Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -40.63% and -45.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for th
Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
03:46pm, Thursday, 06'th May 2021
Alpine Immune Sciences, Inc. (ALPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Alpine (ALPN) Stock?
09:04am, Friday, 16'th Apr 2021
Investors need to pay close attention to Alpine (ALPN) stock based on the movements in the options market lately.
Alpine Immune Sciences Is A Blind Buy After The Recent Price Decrease
05:28pm, Thursday, 15'th Apr 2021
The strategic agreement with AbbVie for the development of ALPN-101 is the most valuable asset of the company. The recent share price decline can be attributed to several factors, including the expect
